Visceral fat area and cardiometabolic risk: The Kardiovize study

POLCROVÁ, Anna, Iuliia PAVLOVSKA, Geraldo A. Maranhao NETO, Šárka KUNZOVÁ, Maria M. INFANTE-GARCIA, Jose R. MEDINA-INOJOSA, Francisco LOPEZ-JIMENEZ, Jeffrey I. MECHANICK, Ramfis NIETO-MARTINEZ, Gorazd Bernard STOKIN, Hynek PIKHART and Juan P. GONZALEZ-RIVAS. Visceral fat area and cardiometabolic risk: The Kardiovize study. Obesity Research & Clinical Practice. OXFORD: ELSEVIER SCI LTD, 2021, vol. 15, No 4, p. 368-374. ISSN 1871-403X. Available from: https://dx.doi.org/10.1016/j.orcp.2021.03.005.

Basic information

Original name

Visceral fat area and cardiometabolic risk: The Kardiovize study

Authors

POLCROVÁ, Anna (203 Czech Republic, guarantor, belonging to the institution), Iuliia PAVLOVSKA (804 Ukraine, belonging to the institution), Geraldo A. Maranhao NETO (203 Czech Republic), Šárka KUNZOVÁ (203 Czech Republic), Maria M. INFANTE-GARCIA (862 Bolivarian Republic of Venezuela), Jose R. MEDINA-INOJOSA (840 United States of America), Francisco LOPEZ-JIMENEZ (840 United States of America), Jeffrey I. MECHANICK (840 United States of America), Ramfis NIETO-MARTINEZ (862 Bolivarian Republic of Venezuela), Gorazd Bernard STOKIN (203 Czech Republic), Hynek PIKHART (203 Czech Republic, belonging to the institution) and Juan P. GONZALEZ-RIVAS (840 United States of America)

Edition

Obesity Research & Clinical Practice, OXFORD, ELSEVIER SCI LTD, 2021, 1871-403X

---

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30308 Nutrition, Dietetics

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 5.214

RIV identification code

RIV/00216224:14310/21:00121420

Organization unit

Faculty of Science

DOI

http://dx.doi.org/10.1016/j.orcp.2021.03.005

UT WoS

000675529000010

Keywords in English

Intra-abdominal fat; Cardiometabolic risk factors; Race factors

Tags

14110525, podil

Tags

International impact, Reviewed

---

Abstract

V originále

Background: Visceral fat is associated with adiposity-based complications. Bioimpedance measurement allows estimation of visceral fat area (VFA) in an easy manner. However, a validated cut-off value for VFA by bioimpedance associated with cardiometabolic risk is lacking in European population. Aim: To determine cut-off values of VFA measured via bioimpedance associated with cardiometabolic risk. Methods: Random cross-sectional Czech population-based sample of 25-64 years old subjects. Receiver Operating Characteristic (ROC) curves were used and the area under the curve (AUC), sensitivity, and specificity were calculated. The Cardiometabolic Disease Staging System (CMDS) was used to classify cardiometabolic risk: Stage 1 - 1 or 2 metabolic syndrome (MetS) components, without impaired fasting glucose (IFG); Stage 2 - MetS or IFG; Stage 3 - MetS with IFG; Stage 4 - type 2 diabetes and/or cardiovascular disease. Results: 2052 participants (54.5% females, median age 49 years) were included. Median VFA (inter-quartile range) were 82.2 cm(2) (54.8) in men and 89.8 cm(2) (55.6) in women. The best VFA cut-offs associated with Stage 1 in men and women were 71 cm(2)(sensitivity = 0.654; specificity = 0.427) and 83 cm(2) (sensitivity = 0.705; specificity = 0.556); Stage 2: 84 cm(2) (sensitivity = 0.673; specificity = 0.551) and 98 cm(2) (sensitivity = 0.702; specificity = 0.628); Stage 3: 90 cm(2) (sensitivity = 0.886; specificity = 0.605) and 109 cm(2) (sensitivity = 0.755; specificity = 0.704); Stage 4: 91 cm(2)(sensitivity = 0.625; specificity = 0.611) and 81cm(2) (sensitivity = 0.695; specificity = 0.448), respectively. Conclusion: A cut-off value of VFA of 71 cm(2) in men and 83 cm(2) in women exhibited the earliest stage of cardiometabolic risk, and 90 cm(2) in men and 109 cm(2) in women showed the best performance to detect risk.